ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0657

Assessing Patient Transition Outcomes from a Large Pediatric Rheumatology Center to Adult Healthcare

Mary Robichaux1, Bernard Danna2, Monique Maher2, David McDonald1, Kristiana Nasto1, Alexander Alexander1, Ariel Coleman3, Danielle Guffey1 and Tiphanie Vogel1, 1Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 3Texas Children's Hospital, Houston, TX

Meeting: ACR Convergence 2021

Keywords: Pediatric rheumatology, quality improvement, Transition

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Session Title: Measures & Measurement of Healthcare Quality Poster (0623–0659)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Transitioning children with chronic diseases from pediatric to adult healthcare can be a challenging task, with high morbidity and mortality. In response, we have developed a transition pathway called the Baylor Rheumatology Initiative: Developing and Guiding Engagement (BRIDGE). Through the BRIDGE, patients are introduced to a clinic-specific transition policy, and providers are incentivized to discuss transition planning beginning in early adolescence, with the goal of effective transition to an adult provider. The Transition Planning Tool (TPT) is an electronic medical record-based flowsheet; TPT use is encouraged at clinic visits for patients aged 14-19. Our objective was to assess baseline transition outcomes for a legacy group of transitioned patients and to assess the correlation between TPT utilization and the rate of successful transition.

Methods: Twenty-seven patients who transitioned during the establishment of the BRIDGE pathway were followed for 1 year post-transition to assess the characteristics of their transition. TPT data was reviewed retrospectively for each patient, examining extent of TPT use and completion of TPT elements. We rigorously defined the primary outcome of successful transition as meeting all 3 of the following criteria: 1) first adult rheumatology appointment within 3 months from last pediatric visit; 2) prescriptions refilled from the adult provider within 3 months from transition; and 3) no rheumatology-related emergency (ER) visits or hospital admissions within 1 year of transition. Comparisons were made using Wilcoxon rank sum, Chi-square, and Fisher’s exact tests.

Results: The majority of transitioned patients were female (78%) and privately insured (67%). The most common diagnosis was SLE (33%). Forty-four percent of patients met all goals for successful transition; 67% attended an adult appointment within 3 months (81% did within 4 months), 59% refilled medications within 3 months, and 85% avoided a rheumatology-related admission or ER visit within 1 year. There was no statistical significance between successfully transitioned patients and those who were not in number of times the TPT was accessed, number of unique TPT questions successfully answered, age, sex, diagnosis, insurance type, or disease severity. However, unadjusted logistic regression indicated that completion of some TPT questions, specifically #8 regarding alcohol/non-prescription drug use and #13 knowing who the adult provider will be, was associated with a higher probability of successful transition.

Conclusion: Although there is no significant link between TPT use and successful transition in this legacy cohort, there are some positive signals. For our next step, we will compare these outcomes to those of patients who have been in our formalized BRIDGE program for 1 year or longer before transition. Additionally, over the next quality improvement cycle, we hope to achieve successful transition metrics for 75% of our patients.


Disclosures: M. Robichaux, None; B. Danna, None; M. Maher, None; D. McDonald, None; K. Nasto, None; A. Alexander, None; A. Coleman, None; D. Guffey, None; T. Vogel, None.

To cite this abstract in AMA style:

Robichaux M, Danna B, Maher M, McDonald D, Nasto K, Alexander A, Coleman A, Guffey D, Vogel T. Assessing Patient Transition Outcomes from a Large Pediatric Rheumatology Center to Adult Healthcare [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/assessing-patient-transition-outcomes-from-a-large-pediatric-rheumatology-center-to-adult-healthcare/. Accessed January 28, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-patient-transition-outcomes-from-a-large-pediatric-rheumatology-center-to-adult-healthcare/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences